Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 9
1966 7
1967 13
1968 16
1969 14
1970 14
1971 14
1972 21
1973 22
1974 29
1975 57
1976 45
1977 45
1978 54
1979 59
1980 53
1981 58
1982 65
1983 88
1984 52
1985 68
1986 61
1987 75
1988 72
1989 57
1990 85
1991 72
1992 81
1993 81
1994 88
1995 104
1996 97
1997 96
1998 66
1999 72
2000 63
2001 59
2002 54
2003 54
2004 65
2005 61
2006 50
2007 67
2008 60
2009 47
2010 58
2011 48
2012 52
2013 59
2014 50
2015 54
2016 44
2017 41
2018 32
2019 49
2020 40
2021 36
2022 37
2023 30
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

2,989 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics of indomethacin.
Alván G, Orme M, Bertilsson L, Ekstrand R, Palmér L. Alván G, et al. Clin Pharmacol Ther. 1975 Sep;18(3):364-73. doi: 10.1002/cpt1975183364. Clin Pharmacol Ther. 1975. PMID: 1100305 Clinical Trial.
Plasma concentrations of indomethacin have been studied in 5 healthy volunteers after single and multiple doses (25 mg intravenously [iv], 25, 50, and 100 mg orally, 100 mg rectally, and 25 mg three times daily [tid]. In 8 other normal subjects and in 5 patients a 50-mg or …
Plasma concentrations of indomethacin have been studied in 5 healthy volunteers after single and multiple doses (25 mg intravenously …
Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders.
Baber N, Halliday LD, van den Heuvel WJ, Walker RW, Sibeon R, Keenan JP, Littler T, Orme ML. Baber N, et al. Ann Rheum Dis. 1979 Apr;38(2):128-36. doi: 10.1136/ard.38.2.128. Ann Rheum Dis. 1979. PMID: 375848 Free PMC article. Clinical Trial.
Twenty patients with definite or classical rheumatoid arthritis entered and completed a sequential study of placebo for 1 week, oral indomethacin 25 mg 3 times a day for 3 weeks, and oral indomethacin 25 mg 3 times a day plus 100 mg indomethacin suppository a …
Twenty patients with definite or classical rheumatoid arthritis entered and completed a sequential study of placebo for 1 week, oral indo
Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial.
Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, Duncan CC, Scott DT, Taylor KJ, Katz KH, et al. Ment LR, et al. Pediatrics. 1994 Apr;93(4):543-50. Pediatrics. 1994. PMID: 8134206 Clinical Trial.
Sixteen indomethacin-treated neonates and 29 control neonates died (P = .08); there was a difference favoring indomethacin with respect to survival time (P = .06). ...There were no differences in adverse events attributed to indomethacin between the two treat …
Sixteen indomethacin-treated neonates and 29 control neonates died (P = .08); there was a difference favoring indomethacin wit …
Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor.
Besinger RE, Niebyl JR, Keyes WG, Johnson TR. Besinger RE, et al. Am J Obstet Gynecol. 1991 Apr;164(4):981-6; discussion 986-8. doi: 10.1016/0002-9378(91)90569-d. Am J Obstet Gynecol. 1991. PMID: 2014850 Clinical Trial.
Successful intravenous ritodrine therapy was followed by oral terbutaline therapy, and indomethacin-treated patients continued to receive oral indomethacin. ...However, three cases of primary pulmonary hypertension were observed in the indomethacin group. We …
Successful intravenous ritodrine therapy was followed by oral terbutaline therapy, and indomethacin-treated patients continued to rec …
Indomethacin for heterotopic ossification prophylaxis following surgical treatment of elbow trauma: a randomized controlled trial.
Atwan Y, Abdulla I, Grewal R, Faber KJ, King GJW, Athwal GS. Atwan Y, et al. J Shoulder Elbow Surg. 2023 Jun;32(6):1242-1248. doi: 10.1016/j.jse.2023.02.119. Epub 2023 Mar 11. J Shoulder Elbow Surg. 2023. PMID: 36907317 Clinical Trial.
BACKGROUND: Heterotopic ossification is a frequent complication following surgical treatment of elbow trauma. The use of indomethacin to prevent heterotopic ossification is reported in the literature; however, its effectiveness is controversial. ...RESULTS: At 1-year follo …
BACKGROUND: Heterotopic ossification is a frequent complication following surgical treatment of elbow trauma. The use of indomethacin
Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of rheumatoid arthritis: a comparative controlled clinical trial.
Crowley B, Hamill JJ, Lyndon S, McKellican JF, Williams P, Miller AJ. Crowley B, et al. Curr Med Res Opin. 1990;12(3):143-50. doi: 10.1185/03007999009111495. Curr Med Res Opin. 1990. PMID: 2272188 Clinical Trial.
The efficacy and tolerability of a new, controlled-release indomethacin (75 mg) tablet was compared to that of a sustained-release diclofenac sodium (100 mg) tablet in 84 patients with rheumatoid arthritis. ...It was concluded that controlled-release indomethacin ta …
The efficacy and tolerability of a new, controlled-release indomethacin (75 mg) tablet was compared to that of a sustained-release di …
Indomethacin sustained-release?
Green JA. Green JA. Drug Intell Clin Pharm. 1984 Dec;18(12):1004-7. doi: 10.1177/106002808401801222. Drug Intell Clin Pharm. 1984. PMID: 6391883 Review.
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulation. The literature on indomethacin was examined with respect to the above conditions and it was concluded that its marketing as a sust …
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulatio …
A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.
Adams KR, Halliday LD, Sibeon RG, Baber N, Littler T, Orme ML. Adams KR, et al. Br J Clin Pharmacol. 1982 Aug;14(2):286-9. doi: 10.1111/j.1365-2125.1982.tb01977.x. Br J Clin Pharmacol. 1982. PMID: 7104182 Free PMC article. Clinical Trial.
Fifteen patients with rheumatoid arthritis received indomethacin in three treatment schedules; indomethacin retard 75 mg twice daily; indomethacin capsules 50 mg three times daily; and indomethacin 100 mg suppository at night with 50 mg by mouth each m …
Fifteen patients with rheumatoid arthritis received indomethacin in three treatment schedules; indomethacin retard 75 mg twice …
Pharmacokinetics of indomethacin in pregnancy.
Rytting E, Nanovskaya TN, Wang X, Vernikovskaya DI, Clark SM, Cochran M, Abdel-Rahman SM, Venkataramanan R, Caritis SN, Hankins GD, Ahmed MS. Rytting E, et al. Clin Pharmacokinet. 2014 Jun;53(6):545-51. doi: 10.1007/s40262-014-0133-6. Clin Pharmacokinet. 2014. PMID: 24493205 Free PMC article. Clinical Trial.
METHODS: This opportunistic study assessed the steady-state pharmacokinetics of indomethacin in pregnant subjects to whom an oral dose of 25 mg every 6 h was prescribed. Indomethacin concentrations in plasma and urine were analyzed by a validated high-performance li …
METHODS: This opportunistic study assessed the steady-state pharmacokinetics of indomethacin in pregnant subjects to whom an oral dos …
Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial.
Ment LR, Oh W, Ehrenkranz RA, Phillip AG, Vohr B, Allan W, Makuch RW, Taylor KJ, Schneider KC, Katz KH, et al. Ment LR, et al. J Pediatr. 1994 Jun;124(6):951-5. doi: 10.1016/s0022-3476(05)83191-9. J Pediatr. 1994. PMID: 8201485 Clinical Trial.
Four indomethacin-treated and three saline solution-treated infants had parenchymal extension of the hemorrhage. Indomethacin was associated with closure of a patent ductus arteriosus by the fifth day of life (p = 0.003). ...
Four indomethacin-treated and three saline solution-treated infants had parenchymal extension of the hemorrhage. Indomethacin
2,989 results